CHICAGO--(BUSINESS WIRE)-- Allscripts Healthcare Solutions, Inc. announced today that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been ...

The name change, effective Jan. 1, has been underway since 2022, as Allscripts worked to move its products to the new brand, according to a Jan. 3 press release from the company. All remaining ...

Allscripts Healthcare Solutions on Thursday posted a nearly 7% rise in year-over-year second-quarter revenue as it continues to refocus its business on its payer and life sciences division, Veradigm.

Allscripts Healthcare Solutions (NASDAQ:MDRX), the healthcare technology company, has formally changed its name to Veradigm. Veradigm (MDRX) provides services to 300K US healthcare providers via the ...

Veradigm, Allscripts’ payer and life sciences division, joined Boston-based Harvard Pilgrim Health Care Institute and other collaborators to continue developing the FDA’s drug safety database. The FDA ...

UPDATE: Sept. 25, 2023: Veradigm has received notice that its shares will be delisted from the Nasdaq after the health IT company failed to file required financial paperwork before the end of the ...

After shedding its hospital business segment earlier this year, health IT company Allscripts is doubling down on its strategy to grow its payers and life sciences businesses. Allscripts sold its ...

Allscripts Healthcare Solutions, Inc. MDRX delivered adjusted earnings per share (EPS) of 23 cents in the third quarter of 2022, up 9.5% year over year. The figure topped the Zacks Consensus Estimate ...

Allscripts Healthcare Solutions, Inc. MDRX is well poised for growth in the coming quarters, backed by its strategic alliances over the past few months. A robust second-quarter 2021 performance, along ...